March 31, 2026. More for You ...

Since many cancers don’t have symptoms early on, they may go unnoticed until they are at an advanced stage. But that is ...

The FDA approved a once-weekly, long-acting basal insulin for adults with type 2 diabetes as an alternative to daily basal ...

The FDA approved insulin icodec (Awiqli) as the first once-weekly, long-acting basal insulin for glycemic control in adults ...

Some patients with type 2 diabetes will be able to switch from daily insulin injections to this first-of-its-kind once-weekly ...

A new digital film series highlights how lifestyle medicine can treat type 2 diabetes — and, in many cases, even achieve remission.The American College of Lifestyle Medicine (ACLM) launched “Project ...

The American College of Lifestyle Medicine (ACLM) announces the launch of Project Remission: A Lifestyle Medicine Approach to ...

Lacie Lee, DVM, and Adam Christman, DVM, MBA, discuss risk factors, prevention, and individualized management of feline ...

Novo Nordisk’s icodec-abae is now approved in the US for type 2 diabetes only, after a prior rejection partly due to concerns about hypoglycemia in type 1 diabetes.

A new research study provides real-world evidence that deprescribing glucose‑lowering medications is both feasible and safe ...

A new research study provides real-world evidence that deprescribing glucose-lowering medications is both feasible and safe ...

Mass General Brigham researchers found that the intensive cholesterol-lowering therapy evolocumab reduced the risk of a first major cardiovascular event in high-risk patients who did not have known ...